ArticleACG case reports journal2021

Umbralisib-Induced Immune-Mediated Colitis: A Concerning Adverse Effect of the Novel PI3Kδ/CK1ε Inhibitor.

Suryansh Bajaj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.